☆ 4.4 Meeting Abstract

Viral escape in the CNS with multidrug-resistant HIV-1

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)

Journal

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

Volume 17, Issue -, Pages 156-157

Publisher

JOHN WILEY & SONS LTD

DOI: 10.7448/IAS.17.4.19745

Keywords

-

Categories

Immunology Infectious Diseases

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Cell Biology

Epitope length variants balance protective immune responses and viral escape in HIV-1 infection

Phillip Pymm, Stefan Tenzer, Edmund Wee, Mirjana Weimershaus, Anne Burgevin, Simon Kollnberger, Jan Gerstoft, Tracy M. Josephs, Kristin Ladell, James E. McLaren, Victor Appay, David A. Price, Lars Fugger, John I. Bell, Hansjoerg Schild, Peter van Endert, Maria Harkiolaki, Astrid K. N. Iversen

Summary: This study discovers that the cytotoxic T lymphocyte (CTL) and natural killer (NK) cell responses to a specific epitope in the human immunodeficiency virus are associated with enhanced immune control. The length and mutations of the epitope influence the CTL and NK cell responses, leading to viral escape.

CELL REPORTS (2022)

Add to Collection

Article Medicine, Research & Experimental

HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART

Shelli F. Farhadian, Ofir Lindenbaum, Jun Zhao, Michael J. Corley, Yunju Im, Hannah Walsh, Alyssa Vecchio, Rolando Garcia-Milian, Jennifer Chiarella, Michelle Chintanaphol, Rachela Calvi, Guilin Wang, Lishomwa C. Ndhlovu, Jennifer Yoon, Diane Trotta, Shuangge Ma, Yuval Kluger, Serena Spudich

Summary: People with HIV on antiretroviral therapy experience neurological impairment, possibly due to viral or neuroimmune causes. Single-cell analysis of paired cerebrospinal fluid and peripheral blood revealed the production of HIV-1 RNA in central memory CD4+ T cells in the cerebrospinal fluid, as well as a higher frequency of infected cells in the cerebrospinal fluid compared to the blood. Additionally, rare microglia-like cells in the cerebrospinal fluid were identified using a reliable cell surface marker, CD204. Abnormal CD8+ T cell activation was found to be prevalent in the cerebrospinal fluid of people with HIV, suggesting ongoing CNS viral persistence and compartmentalized neuroimmune effects.

JCI INSIGHT (2022)

Add to Collection

Article Infectious Diseases

High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana

Nametso Kelentse, Sikhulile Moyo, Wonderful T. Choga, Kwana Lechiile, Tshepo B. Leeme, David S. Lawrence, Ishmael Kasvosve, Rosemary Musonda, Mosepele Mosepele, Thomas S. Harrison, Joseph N. Jarvis, Simani Gaseitsiwe

Summary: This study compared the patterns of HIV-1 drug resistance mutations between the cerebrospinal fluid (CSF) and plasma of individuals with HIV-associated cryptococcal meningitis. The results showed high concordance in HIV-1 drug resistance mutations between the CSF and plasma, suggesting intercompartmental mixing and possibly a lack of compartmentalization. Some individuals also harbored minority HIV-1 drug resistance mutations.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Add to Collection

Article Infectious Diseases

Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV

Daniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, Luca Carioti, Laura Galli, Andrea Galli, Rossana Scutari, Eleonora Salsi, Cristina Mussini, Gaetana Sterrantino, Leonardo Calza, Barbara Rossetti, Maurizio Zazzi, Antonella Castagna

Summary: The study found that heavily treatment-experienced individuals with multidrug-resistant HIV had high levels of drug resistance mutational load but less pronounced APOBEC editing. Patients who failed treatment showed higher levels of DNA resistance and mutational load compared to those who responded.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

Add to Collection

Article Infectious Diseases

Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry

Francesco Saladini, Federica Giammarino, Franco Maggiolo, Micol Ferrara, Giovanni Cenderello, Benedetto M. Celesia, Ferdinando Martellotta, Vincenzo Spagnuolo, Giulio M. Corbelli, Nicola Gianotti, Maria M. Santoro, Stefano Rusconi, Maurizio Zazzi, Antonella Castagna

Summary: This study evaluated the phenotypic susceptibility of multidrug-resistant (MDR) HIV-1 isolates to doravirine, rilpivirine, and etravirine. Despite extensive cross-resistance among NNRTIs, doravirine can still be a valid option for PLWH with MDR HIV-1.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Add to Collection

Article Multidisciplinary Sciences

Prolonged viral suppression with anti-HIV-1 antibody therapy

Christian Gaebler, Lilian Nogueira, Elina Stoffel, Thiago Y. Oliveira, Gaelle Breton, Katrina G. Millard, Martina Turroja, Allison Butler, Victor Ramos, Michael S. Seaman, Jacqueline D. Reeves, Christos J. Petroupoulos, Irina Shimeliovich, Anna Gazumyan, Caroline S. Jiang, Nikolaus Jilg, Johannes F. Scheid, Rajesh Gandhi, Bruce D. Walker, Michael C. Sneller, Anthony Fauci, Tae-Wook Chun, Marina Caskey, Michel C. Nussenzweig

Summary: Immunotherapy with anti-HIV-1 antibodies has the potential to suppress infection and increase the rate of clearance of infected cells. A clinical study showed that 76% of HIV-infected individuals who received a combination of antibodies maintained virologic suppression for at least 20 weeks without antiretroviral therapy. The administration of antibodies affected the HIV-1 reservoir, but further research is needed to define the precise effect of antibody immunotherapy.

NATURE (2022)

Add to Collection

Article Medicine, General & Internal

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

Sorana Segal-Maurer, Edwin DeJesus, Hans-Jurgen Stellbrink, Antonella Castagna, Gary J. Richmond, Gary I. Sinclair, Krittaecho Siripassorn, Peter J. Ruane, Mezgebe Berhe, Hui Wang, Nicolas A. Margot, Hadas Dvory-Sobol, Robert H. Hyland, Diana M. Brainard, Martin S. Rhee, Jared M. Baeten, Jean-Michel Molina

Summary: Patients with multidrug-resistant HIV-1 infection showed greater reduction in viral load when treated with lenacapavir compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Immunology

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana

Baitshepi Mokaleng, Wonderful Tatenda Choga, Ontlametse Thato Bareng, Dorcas Maruapula, Doreen Ditshwanelo, Nametso Kelentse, Patrick Mokgethi, Natasha Onalenna Moraka, Modisa Sekhamo Motswaledi, Leabaneng Tawe, Catherine Kegakilwe Koofhethile, Sikhulile Moyo, Matshediso Zachariah, Simani Gaseitsiwe

Summary: HIV accumulates escape mutations in response to immune response, and the prevalence of CTL escape mutations in Botswana remains similar between two time points. The P17 protein has the most mutations, and unique mutations are found in both early and late time point sequences.

VACCINES (2023)

Add to Collection

Article Microbiology

Adaptation of HIV-1/HIV-2 Chimeras with Defects in Genome Packaging and Viral Replication

Jonathan M. O. Rawson, Olga A. Nikolaitchik, Jennifer A. Yoo, Xayathed Somoulay, Matthew A. Brown, Franck S. Mbuntcha Bogni, Vinay K. Pathak, Ferri Soheilian, Ryan L. Slack, Stefan G. Sarafianos, Wei-Shau Hu

Summary: Novel retroviruses can emerge from recombination between distantly related retroviruses. These recombinants may initially have replication defects, but they can adapt and enhance their replication by acquiring substitutions.

MBIO (2022)

Add to Collection

Article Multidisciplinary Sciences

Maturation of the matrix and viral membrane of HIV-1

Kun Qu, Zunlong Ke, Vojtech Zila, Maria Anders-Oesswein, Barbel Glass, Frauke Muecksch, Rainer Mueller, Carsten Schultz, Barbara Mueller, Hans-Georg Kraeusslich, John A. G. Briggs

Summary: The study found that MA rearranges between different hexameric lattices in the maturation process of HIV-1, binding with lipid extending out of the membrane in mature HIV-1. The data suggest that proteolytic maturation of HIV-1 assembles the viral capsid and repurposes the membrane-bound MA lattice for cell entry or post-entry function, resulting in the removal of up to 2500 lipids from the viral membrane.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Learning the language of viral evolution and escape

Brian Hie, Ellen D. Zhong, Bonnie Berger, Bryan Bryson

Summary: Researchers used machine learning algorithms to model viral escape and identified patterns in escape mutations, showing that language models can accurately predict viral escape patterns similar to how words can change the meaning of a sentence. This study represents a promising conceptual bridge between natural language and viral evolution.

SCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana

Nametso Kelentse, Sikhulile Moyo, Kesaobaka Molebatsi, Olorato Morerinyane, Shatho Bitsang, Ontlametse T. Bareng, Kwana Lechiile, Tshepo B. Leeme, David S. Lawrence, Ishmael Kasvosve, Rosemary Musonda, Mosepele Mosepele, Thomas S. Harrison, Joseph N. Jarvis, Simani Gaseitsiwe

Summary: This study investigated CSF viral escape and HIV-1 viral load in individuals treated for HIV-associated cryptococcal meningitis. The results showed a decreasing trend of CSF viral escape during antifungal treatment, indicating the potential of antifungal therapy in reversing CSF viral escape.

BIOMEDICINES (2022)

Add to Collection

Article Multidisciplinary Sciences

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody

Matthijs Meijers, Kanika Vanshylla, Henning Gruell, Florian Klein, Michael Laessig

Summary: Broadly neutralizing antibodies show promise in treating and preventing HIV-1 infections, but the virus often evolves resistance. A fitness model based on in vivo data accurately predicts the dynamics of HIV-1 escape during antibody treatment, highlighting an evolutionary trade-off between antibody resistance and its collateral cost.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Review Microbiology

The Interplay of HIV-1 and Macrophages in Viral Persistence

Chynna M. Hendricks, Thaissa Cordeiro, Ana Paula Gomes, Mario Stevenson

Summary: HIV-1 utilizes latent cellular reservoirs, including tissue resident macrophages, to persist in the host despite antiretroviral therapies. Current strategies are ineffective in eliminating these reservoirs, highlighting the need to focus on eradicating them for a potential functional cure in the future.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Critical mechanistic features of HIV-1 viral capsid assembly

Manish Gupta, Alexander J. Pak, Gregory A. Voth

Summary: Researchers use molecular dynamics simulations to reveal the molecular mechanism of HIV-1 capsid formation, including the role of IP6. This study shows that IP6 initially promotes curvature generation by trapping pentameric defects and shifts the assembly behavior towards kinetically favored outcomes. Additionally, IP6 can stabilize metastable capsid intermediates and induce structural pleomorphism in mature capsids.

SCIENCE ADVANCES (2023)

Add to Collection

Article Immunology

Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection

Eveline Hofmann, Bernard Surial, Noemie Boillat-Blanco, Huldrych F. Guenthard, Marcel Stoeckle, Enos Bernasconi, Patrick Schmid, Alexandra Calmy, Franziska Suter-Riniker, Andri Rauch, Gilles Wandeler, Charles Beguelin

Summary: In the Swiss HIV Cohort Study, researchers found that 27% of HIV-suppressed individuals with chronic hepatitis B virus (HBV) infection had HBV replication after two years on tenofovir. However, 77% of them were able to achieve suppression thereafter. Self-reported adherence to therapy and HBV viral load at tenofovir initiation were identified as predictors of persistent replication.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis delta infection among persons living with HIV in Europe

Charles Beguelin, Andrew Atkinson, Anders Boyd, Karolin Falconer, Nikolai Kirkby, Franziska Suter-Riniker, Huldrych F. Guenthard, Juergen K. Rockstroh, Amanda Mocroft, Andri Rauch, Lars Peters, Gilles Wandeler

Summary: A study found a high prevalence of hepatitis delta virus (HDV) infection among persons living with HIV (PLWH) in Europe, which is the most severe form of viral hepatitis. This study analyzed data from a large HIV cohort collaboration to characterize the epidemiological trends of HDV in Europe and its impact on clinical outcomes.

LIVER INTERNATIONAL (2023)

Add to Collection

Article Infectious Diseases

Prevalence of STIs and people's satisfaction in a general population STI testing site in Bern, Switzerland

Dina Bigler, Bernard Surial, Christoph Victor Hauser, Torsten Konrad, Hansjakob Furrer, Andri Rauch, Karoline Aebi-Popp

Summary: Access to affordable STI testing for asymptomatic individuals is important to reduce STI transmission. Our study examines the prevalence of STIs and the factors motivating people to attend our easily accessible and affordable testing site.

SEXUALLY TRANSMITTED INFECTIONS (2023)

Add to Collection

Article Medicine, General & Internal

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019

Daniela K. van Santen, Rachel Sacks-Davis, Ashleigh Stewart, Anders Boyd, Jim Young, Marc van der Valk, Colette Smit, Andri Rauch, Dominique L. Braun, Inmaculada Jarrin, Juan Berenguer, Jeffrey V. Lazarus, Karine Lacombe, Maria-Bernarda Requena, Linda Wittkop, Olivier Leleux, Dominique Salmon, Fabrice Bonnet, Gail Matthews, Joseph S. Doyle, Tim Spelman, Marina B. Klein, Maria Prins, Jason Asselin, Mark A. Stoove, Margaret Hellard

Summary: We assessed the impact of broad direct-acting antiviral (DAA) access on hepatitis C virus (HCV) incidence among people living with HIV (PLHIV) and found that it can significantly reduce HCV incidence, indicating a treatment as prevention effect.

ECLINICALMEDICINE (2023)

Add to Collection

Article Immunology

Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation

Mathieu Chalouni, Adam Trickey, Suzanne M. Ingle, Maria Antonia Sepuvelda, Juan Gonzalez, Andri M. Rauch, Heidi M. Crane, M. John Gill, Peter F. Rebeiro, Jurgen K. Rockstroh, Ricardo A. Franco, Giota Touloumi, Didier Neau, Montserrat Laguno, Michaela Rappold, Colette Smit, Jonathan A. C. Sterne, Linda Wittkop

Summary: Reaching SVR in HIV/HCV co-infected individuals significantly reduces mortality, but there may still be a higher risk of non-AIDS nonliver cancers compared to mono-infected individuals. Monitoring of these events following SVR is necessary.

AIDS (2023)

Add to Collection

Article Obstetrics & Gynecology

Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV

Pierre Alex Crisinel, Katharina Kusejko, Christian R. Kahlert, Noemie Wagner, Leila Sultan Beyer, Martinez De Tejada, Irene Hosli, Malte Kohns Vasconcelos, Marc Baumann, Katharine Darling, Andrea Duppenthaler, Andri Rauch, Paolo Paioni, Karoline Aebi-Popp

Summary: Swiss national recommendations support HIV-infected women who wish to breastfeed. This study found that the main motivating factors for these women to breastfeed were bonding, neonatal and maternal health benefits. No breastfed infant acquired HIV transmission.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies

Adam M. Trickey, Suzanne Ingle, Anders Boyd, M. John Gill, Sophie Grabar, Inma Jarrin, Niels Obel, Giota Touloumi, Robert Zangerle, Andri T. Rauch, Christopher D. Rentsch, Derek J. Satre, Michael Silverberg, Fabrice Bonnet, Jodie Guest, Greer Burkholder, Heidi Crane, Ramon Teira, Juan Berenguer, Christoph Wyen, Sophie Abgrall, Mojgan Hessamfar, Peter Reiss, Antonella A. d'Arminio Monforte, Kathleen McGinnis, Jonathan A. C. Sterne, Linda Wittkop

Summary: Among persons with HIV, higher alcohol use and having hepatitis C virus are associated with increased morbidity and mortality. This study investigated the interaction between alcohol use and hepatitis C virus on mortality in HIV-positive individuals. The results showed a J-shaped pattern of mortality among HIV-positive individuals without hepatitis C virus, with both non-drinkers and heavy drinkers having higher mortality compared to moderate alcohol drinkers. However, among those with hepatitis C virus, only heavy drinkers had higher mortality rates.

JOURNAL OF VIRAL HEPATITIS (2023)

Add to Collection

Article Immunology

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course

Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly A. Murray, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podesvova, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco B. L. Rocchi, Luca Varani, Bernhard Moser, Barbara Bottazzi, Marcus Thelen, Brian A. Fallon, Onur Boyman, Alberto Mantovani, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F. Robbiani

Summary: We found that antibodies against specific chemokines are commonly present in COVID-19 convalescents and are associated with favorable disease outcomes and a decreased risk of long COVID development at 1 year post-infection. These chemokine antibodies are also found in HIV-1 infection and autoimmune disorders, but target different chemokines compared to COVID-19. Monoclonal antibodies derived from COVID-19 convalescents that bind to the chemokine N-loop impair cell migration. Naturally occurring chemokine antibodies may modulate the inflammatory response and have therapeutic potential.

NATURE IMMUNOLOGY (2023)

Add to Collection

Article Infectious Diseases

Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy

Lorin Begre, Anders Boyd, Luisa Salazar-Vizcaya, Franziska Suter-Riniker, Charles Beguelin, Juergen K. Rockstroh, Huldrych F. Guenthard, Alexandra Calmy, Matthias Cavassini, Marcel Stoeckle, Patrick Schmid, Enos Bernasconi, Massimo Levrero, Fabien Zoulim, Gilles Wandeler, Andri Rauch, Swiss HIV Cohort Study SHCS

Summary: In HIV patients with HBsAg loss, qHBsAg levels decline rapidly at the beginning and then show diverse trajectories during long-term tenofovir therapy. In patients without HBsAg loss, qHBsAg levels remain relatively stable over time.

HIV MEDICINE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study

Lukas Baumann, Dominique L. Braun, Matthias Cavassini, Marcel Stoeckle, Enos Bernasconi, Patrick Schmid, Alexandra Calmy, David Haerry, Charles Beguelin, Christoph A. Fux, Gilles Wandeler, Bernard Surial, Andri Rauch

Summary: The study assessed the changes in the prevalence of replicating HCV infection, treatment uptake, and liver-related morbidity and mortality in persons with HIV and hepatitis C. The introduction of direct-acting antiviral therapy was associated with a significant reduction in the prevalence of replicating HCV infection, as well as a decrease in overall mortality and incidence of liver-related events in this population.

LIVER INTERNATIONAL (2023)

Add to Collection

Article Multidisciplinary Sciences

Africa-specific human genetic variation near CHD1L associates with HIV-1 load

Paul J. J. McLaren, Immacolata Porreca, Gennaro Iaconis, Hoi Ping Mok, Subhankar Mukhopadhyay, Emre Karakoc, Sara Cristinelli, Cristina Pomilla, Istvan Bartha, Christian W. W. Thorball, Riley H. H. Tough, Paolo Angelino, Cher S. S. Kiar, Tommy Carstensen, Segun Fatumo, Tarryn Porter, Isobel Jarvis, William C. C. Skarnes, Andrew Bassett, Marianne K. K. DeGorter, Mohana Prasad Sathya Moorthy, Jeffrey F. F. Tuff, Eun-Young Kim, Miriam Walter, Lacy M. M. Simons, Arman Bashirova, Susan Buchbinder, Mary Carrington, Andrea Cossarizza, Andrea De Luca, James J. J. Goedert, David B. B. Goldstein, David W. W. Haas, Joshua T. T. Herbeck, Eric O. O. Johnson, Pontiano Kaleebu, William Kilembe, Gregory D. D. Kirk, Neeltje A. A. Kootstra, Alex H. H. Kral, Olivier Lambotte, Ma Luo, Simon Mallal, Javier Martinez-Picado, Laurence Meyer, Jose M. Miro, Pravi Moodley, Ayesha A. A. Motala, James I. I. Mullins, Kireem Nam, Niels Obel, Fraser Pirie, Francis A. A. Plummer, Guido Poli, Matthew A. A. Price, Andri Rauch, Ioannis Theodorou, Alexandra Trkola, Bruce D. D. Walker, Cheryl A. A. Winkler, Jean-Francois Zagury, Stephen B. B. Montgomery, Angela Ciuffi, Judd F. F. Hultquist, Steven M. M. Wolinsky, Gordon Dougan, Andrew M. L. Lever, Deepti Gurdasani, Harriet Groom, Manjinder S. S. Sandhu, Jacques Fellay

Summary: This study identified a previously undescribed association signal on chromosome 1 that is specific to African populations and is associated with lower set-point viral load in individuals living with HIV-1. Experimental studies showed that the gene CHD1L, which is involved in DNA repair, may play a role in limiting HIV-1 replication.

NATURE (2023)

Add to Collection

Article Immunology

T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C

Kamila Caraballo Cortes, Sylwia Osuch, Karol Perlejewski, Marek Radkowski, Maciej Janiak, Hanna Berak, Andri Rauch, Jan S. Fehr, Matthias Hoffmann, Huldrych F. Guenthard, Karin J. Metzner, Swiss HIV Cohort Study

Summary: This study assessed inhibitory receptors and interleukin 10 levels in chronic HIV-1/hepatitis C virus (HCV) coinfection and investigated the effects of HCV treatment on these markers. The results demonstrated increased levels of soluble PD-1 and IL-10 in coinfection, which were reduced following successful HCV treatment. The study also suggested a potential association between inhibitory receptor levels and epitope sequence.

OPEN FORUM INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19

Catrina Mugglin, Kalongo Hamusonde, Luisa Salazar-Vizcaya, Katharina Kusejko, Dunja Nicca, David Haerry, Dominique L. Braun, Marcel Stoeckle, Roger Kouyos, Alexandra Calmy, Matthias Cavassini, Michela Cipriani, Enos Bernasconi, Andri Rauch, Anna Hachfeld, Swiss HIV Cohort Study SHCS

Summary: Despite a decrease in sexual partners, the COVID-19 pandemic had minimal impact on participation in private sex parties, traveling for sex within Switzerland, and chemsex in men with HIV who have sex with men. COVID-19 risk perception was low, and the incidence rates of STI diagnosis remained stable over time.

OPEN FORUM INFECTIOUS DISEASES (2023)

Add to Collection

Article Infectious Diseases

Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

Jelle Koopsen, Gail Matthews, Juergen Rockstroh, Tanya L. Applegate, Sanjay Bhagani, Andri Rauch, Jason Grebely, Rachel Sacks-Davis, Patrick Ingiliz, Christoph Boesecke, Sjoerd Rebers, Jordan Feld, Julie Bruneau, Marianne Martinello, Margaret Hellard, Gregory J. Dore, Janke Schinkel, REACT Study Grp

Summary: This study investigates the international transmission and prevalence of resistance-associated substitutions (RAS) in men who have sex with men (MSM) with recent hepatitis C virus (HCV) infection. The results show that international transmission is common among MSM, but transmission of highly resistant viruses is infrequent.

LANCET MICROBE (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study

Cas J. Isfordink, Anders Boyd, Rachel Sacks-Davis, Daniela K. van Santen, Colette Smit, Marianne Martinello, Mark Stoove, Juan Berenguer, Linda Wittkop, Marina B. Klein, Andri Rauch, Dominique Salmon, Karine Lacombe, Ashleigh Stewart, Janke Schinkel, Joseph S. Doyle, Margaret Hellard, Marc van der Valk, Gail Matthews

Summary: This study compared the rates of direct-acting antiviral treatment uptake in high-income countries for individuals with HIV-HCV, and investigated the reasons for remaining untreated. The results showed that despite unrestricted access, approximately one-third of HIV-HCV individuals did not receive treatment with direct-acting antivirals. Several factors associated with the commencement rate of treatment were identified. Increased efforts are needed to achieve micro-elimination of HIV-HCV by reaching the remaining untreated individuals.

LANCET PUBLIC HEALTH (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.